State Key Laboratory of Coordination Chemistry, and Jiangsu Key Laboratory of Advanced Organic Materials School of Chemistry and Chemical Engineering, Nanjing University, 163 Xianlin Avenue, Nanjing, Jiangsu 210023, China.
Org Biomol Chem. 2022 Nov 9;20(43):8438-8442. doi: 10.1039/d2ob01707e.
Ecteinascidin 743 is a famous marine drug used in anticancer treatments. In this work, a series of simplified hybrids/analogues have been synthesized by employing a newly developed chemistry that integrates the partial structural features of two anticancer bis-tetrahydroisoquinoline alkaloids ecteinascidin 743 and cribrostatin 4. The described Suzuki-coupling protocol enabled us to easily introduce variable functionalities at the C3 position of the basic skeleton of bis-tetrahydroisoquinoline alkaloids for the first time. Cytotoxic examination showed that analogue 21f exhibited inhibitory activities with IC values in the low 10 M range against the proliferation of the cancer cell lines A549, HepG2, and MDA-MB-231. This work reveals that diversifying the C3/C4 olefin in the skeleton of tetrahydroisoquinoline alkaloids is a useful means to generate potential pharmaceuticals.
埃替拉宁 743 是一种用于抗癌治疗的著名海洋药物。在这项工作中,通过采用一种新开发的化学方法,合成了一系列简化的混合体/类似物,该方法整合了两种抗癌双四氢异喹啉生物碱埃替拉宁 743 和 cribrostatin 4 的部分结构特征。所描述的 Suzuki 偶联方案使我们能够首次在双四氢异喹啉生物碱的基本骨架的 C3 位置轻松引入可变功能。细胞毒性试验表明,类似物 21f 对 A549、HepG2 和 MDA-MB-231 癌细胞系的增殖表现出抑制活性,IC 值在低 10μM 范围内。这项工作表明,使四氢异喹啉生物碱骨架中的 C3/C4 烯烃多样化是产生潜在药物的一种有效手段。